Phylo and Chugai collaborate to deploy AI platform in drug discovery
Chugai seeks Japan approval for Enspryng to prevent MOGAD relapses
Chugai posts transcript of FY2026 Q2 financial results conference call
Chugai Pharmaceutical (TSE:4519) Stock Net Margin Strength Challenges Cost Pressure Concerns
Chugai Pharmaceutical reports 1H results
Chugai forecasts FY2026 dividend per share at JPY 132